Congresswoman Barbara Lee Visits Tethys Bioscience
EMERYVILLE, Calif., Jan. 22, 2013 /PRNewswire/ -- California Congresswoman Barbara Lee recently visited Emeryville-based Tethys Bioscience, developers of the PreDx® test, the predictive multi-biomarker blood test that differentiates adults with prediabetes according to their 5-year likelihood of progressing to type 2 diabetes, enabling clinicians to focus additional attention on those at highest imminent risk of disease conversion.
Congresswoman Lee, who has been a strong advocate of biotechnology and medical innovation throughout her 8 terms in Congress, toured the Tethys Clinical Laboratory, where the PreDx test was developed and where over 150,000 PreDx tests have been processed since its commercial launch in 2008. In her comments to Lab personnel, Congresswoman Lee praised the important work that Tethys has done to enable the more effective prevention of type 2 diabetes, which has reached epidemic levels throughout the United States and within the local community.
"Tethys' work to identify and more effectively treat patients at the highest risk for type 2 diabetes is a welcome step forward in our shared mission to reduce the prevalence of this preventable disease," said Congresswoman Barbara Lee. "Type 2 diabetes, among other health conditions, remains widespread among low-income communities and communities of color, and I am optimistic that this work will lead to healthier families and communities in the Bay Area and across the country."
About Congresswoman Barbara Lee
Congresswoman Lee represents the new 13th Congressional District of California. During the 113th Congress, Rep. Lee will continue to serve on the House Appropriations Committee and will also serve on the House Budget Committee and the Steering and Policy Committee. She will continue to work to lift millions of Americans out of poverty, eradicate healthcare disparities, ensure that our country's budget is both fair and balanced, and to invest in the future of all Americans.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
